Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...

Semiconductor Chip and Time Domain Sequencing™ Technology Will Advance Drug Discovery and Diagnostics, Enabling People to Live Healthier and Longer Lives Next-generation single-molecule protein ...

Quantum-Si's technology has potential in drug discovery and biomarker test development. The company's Platinum sequencing platform is set to launch. Platinum sequencing platform expected to drive ...

In a development that could accelerate the discovery of new diagnostics and treatments, researchers have developed a versatile and low-cost technology for targeted sequencing of full-length RNA ...

PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...

According to Jonathan M. Rothberg, Ph.D., CEO, founder, and chairman of Ion Torrent, his company’s semiconductor sequencing technology represents a quantum advancement in DNA sequencing. Ion Torrent™ ...

The most exclusive club in omics has admitted only genomics and transcriptomics, the beneficiaries of single-molecule sequencing technologies that are so powerful they enable highly refined ...

OXFORD, England--(BUSINESS WIRE)--At the Nanopore Community Meeting, Rosemary Sinclair Dokos, Stuart Reid and Lakmal Jayasinghe showed how the Oxford Nanopore sequencing platform’s capabilities ...

Identifying low-abundance monoclonal antibodies within a population of polyclonal antibodies provides insights for various applications, including understanding disease mechanisms, vaccine development ...

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that its wholly owned subsidiary ...